PeerVoice Oncology & Haematology Audio

Education Podcasts >

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

More Information

Location:

United States

Genres:

Education Podcasts

Description:

Language:

English

Website:

http://www.peervoice.com

Email:

podcasts@peervoice.com

Episodes

Aiming Higher in Advanced Cutaneous Squamous Cell Carcinoma: Experts Evaluate the Evidence for Immunotherapy

5/17/2019

Aiming Higher in Advanced Cutaneous Squamous Cell Carcinoma: Experts Evaluate the Evidence for Immunotherapy

Duration:00:28:31

Emerging ‘Tumour-Agnostic’ Oncology Treatment: The Role of the Pathologist in Identifying Neurotrophic Tyrosine Kinase Gene Fusions

5/3/2019

Emerging ‘Tumour-Agnostic’ Oncology Treatment: The Role of the Pathologist in Identifying Neurotrophic Tyrosine Kinase Gene Fusions

Duration:00:25:57

Merging Clinical Trial Results and Reality: The Real-World Implications of Androgen Receptor Antagonists for Non–Metastatic Castration-Resistant Prostate Cancer

4/29/2019

Merging Clinical Trial Results and Reality: The Real-World Implications of Androgen Receptor Antagonists for Non–Metastatic Castration-Resistant Prostate Cancer

Duration:00:29:05

Optimising Outcomes for Young Women With Breast Cancer: The Role of Adjuvant Ovarian Suppression

3/15/2019

Optimising Outcomes for Young Women With Breast Cancer: The Role of Adjuvant Ovarian Suppression

Duration:00:21:04

Managing Patients With HER2-Low Breast Cancer

2/19/2019

Managing Patients With HER2-Low Breast Cancer

Duration:00:14:26

Is There a Cardio-Oncologist in the House? Managing Risk for VTE and Stroke Due to AF in Patients With Cancer

2/7/2019

Is There a Cardio-Oncologist in the House? Managing Risk for VTE and Stroke Due to AF in Patients With Cancer

Duration:00:19:40

The Power of Personalised Medicine: CAR-T Immunotherapy for Treatment of Aggressive Large B-Cell Lymphoma

1/14/2019

The Power of Personalised Medicine: CAR-T Immunotherapy for Treatment of Aggressive Large B-Cell Lymphoma

Duration:00:21:50

Biomarkers in Lung Cancer: Targeting the Right Patient With the Right Therapy

11/26/2018

Biomarkers in Lung Cancer: Targeting the Right Patient With the Right Therapy

Duration:01:14:44

Paroxysmal Nocturnal Haemoglobinuria: Complementing Current Knowledge To Improve Outcomes

9/28/2018

Paroxysmal Nocturnal Haemoglobinuria: Complementing Current Knowledge To Improve Outcomes

Duration:00:28:07

Best Practices for Use of Proteasome Inhibitors in the Treatment of Relapsed/Refractory Multiple Myeloma

9/20/2018

Best Practices for Use of Proteasome Inhibitors in the Treatment of Relapsed/Refractory Multiple Myeloma

Duration:00:19:10

Best Practices in Managing CML

8/17/2018

Best Practices in Managing CML

Duration:00:17:58

Clinical Updates: New Pathways and Strategies in Small-Cell Lung Cancer

7/4/2018

Clinical Updates: New Pathways and Strategies in Small-Cell Lung Cancer

Duration:00:19:06

Improving Treatment Monitoring and Therapy Selection in Metastatic Castration-Resistant Prostate Cancer

6/6/2018

Improving Treatment Monitoring and Therapy Selection in Metastatic Castration-Resistant Prostate Cancer

Duration:00:16:14

Locally Advanced BCC: Selecting the Right Option to Optimise Outcomes in Your Patients

5/11/2018

Locally Advanced BCC: Selecting the Right Option to Optimise Outcomes in Your Patients

Duration:00:18:37

Improving the Long-Term Treatment Plan for Patients With Metastatic Pancreatic Cancer: Insights From San Francisco

5/9/2018

Improving the Long-Term Treatment Plan for Patients With Metastatic Pancreatic Cancer: Insights From San Francisco

Duration:00:08:24

The Treatment Plan for Patients With Nonmetastatic Prostate Cancer in Canada: Optimizing the Journey From The Beginning

5/3/2018

The Treatment Plan for Patients With Nonmetastatic Prostate Cancer in Canada: Optimizing the Journey From The Beginning

Duration:00:26:09

Emerging Biomarkers in Small-Cell Lung Cancer: A New Era

4/30/2018

Emerging Biomarkers in Small-Cell Lung Cancer: A New Era

Duration:00:16:43

Improving Outcomes in Later Lines of Therapy for Metastatic Colorectal Cancer

4/11/2018

Improving Outcomes in Later Lines of Therapy for Metastatic Colorectal Cancer

Duration:00:18:45

New Strategies, New Targets: The Evolving Landscape in Driver-Mutation–Positive Advanced NSCLC

4/9/2018

New Strategies, New Targets: The Evolving Landscape in Driver-Mutation–Positive Advanced NSCLC

Duration:00:11:02

Improving Outcomes for VTE in Cancer: The Role of Oral Anticoagulants

3/19/2018

Improving Outcomes for VTE in Cancer: The Role of Oral Anticoagulants

Duration:00:20:05